Valentina Ambrosini

8.2k total citations · 2 hit papers
153 papers, 5.3k citations indexed

About

Valentina Ambrosini is a scholar working on Epidemiology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Valentina Ambrosini has authored 153 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Epidemiology, 72 papers in Oncology and 51 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Valentina Ambrosini's work include Neuroendocrine Tumor Research Advances (74 papers), Neuroblastoma Research and Treatments (46 papers) and Lung Cancer Research Studies (46 papers). Valentina Ambrosini is often cited by papers focused on Neuroendocrine Tumor Research Advances (74 papers), Neuroblastoma Research and Treatments (46 papers) and Lung Cancer Research Studies (46 papers). Valentina Ambrosini collaborates with scholars based in Italy, United States and Germany. Valentina Ambrosini's co-authors include Stefano Fanti, Cristina Nanni, Domenico Rubello, Davide Campana, Paolo Castellucci, Paola Tomassetti, Roberto Franchi, Vincenzo Allegri, Richard P. Baum and Arturo Chiti and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Molecular Sciences.

In The Last Decade

Valentina Ambrosini

147 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA

2017 310 citations Domenico Rubello, Valentina Ambrosini et al. European Journal of Nuclear Medicine and Molecular Imaging profile →
European Neuroendocrine Tumor Society ( ENETS ) 2023 guidance paper for digestive neuroendocrine carcinoma

2023 75 citations Halfdan Sørbye, Enrique Grande et al. Journal of Neuroendocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Valentina Ambrosini Italy	41	2.6k	2.5k	1.8k	1.6k	1.4k	153	5.3k
Marta Cremonesi Italy	42	2.8k 1.1×	2.6k 1.0×	1.6k 0.9×	3.3k 2.0×	1.2k 0.9×	140	6.4k
Chiara Maria Grana Italy	34	2.3k 0.9×	2.2k 0.9×	1.6k 0.9×	1.6k 0.9×	620 0.4×	115	4.3k
Yusuf Menda United States	34	1.5k 0.6×	1.6k 0.6×	1.1k 0.6×	1.3k 0.8×	800 0.6×	123	3.8k
Francesco Giammarile France	35	1.1k 0.4×	1.3k 0.5×	1.3k 0.7×	1.6k 1.0×	884 0.6×	178	4.5k
Samer Ezziddin Germany	37	1.6k 0.6×	1.8k 0.7×	1.1k 0.6×	1.9k 1.1×	1.4k 1.0×	182	4.0k
Boen L.R. Kam Netherlands	30	3.6k 1.4×	3.2k 1.3×	2.6k 1.4×	1.2k 0.7×	334 0.2×	47	4.7k
Hojjat Ahmadzadehfar Germany	42	1.7k 0.6×	2.4k 1.0×	1.1k 0.6×	3.2k 1.9×	2.7k 2.0×	201	5.5k
Irfan Kayani United Kingdom	30	1.0k 0.4×	1.1k 0.5×	801 0.4×	940 0.6×	764 0.6×	76	2.7k
Diane Reidy‐Lagunes United States	38	3.0k 1.2×	4.3k 1.7×	2.1k 1.2×	299 0.2×	683 0.5×	173	5.5k
Vittoria Rufini Italy	34	1.2k 0.5×	975 0.4×	1.0k 0.6×	1.1k 0.6×	492 0.4×	181	3.8k

Countries citing papers authored by Valentina Ambrosini

Since Specialization

Citations

This map shows the geographic impact of Valentina Ambrosini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valentina Ambrosini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valentina Ambrosini more than expected).

Fields of papers citing papers by Valentina Ambrosini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valentina Ambrosini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valentina Ambrosini. The network helps show where Valentina Ambrosini may publish in the future.

Co-authorship network of co-authors of Valentina Ambrosini

This figure shows the co-authorship network connecting the top 25 collaborators of Valentina Ambrosini. A scholar is included among the top collaborators of Valentina Ambrosini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valentina Ambrosini. Valentina Ambrosini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Lamberti, Giuseppe, Francesco Panzuto, Marianne Pavel, et al.. (2024). Gastric neuroendocrine neoplasms. Nature Reviews Disease Primers. 10(1). 25–25. 14 indexed citations

2.

Mosconi, Cristina, Claudio Malizia, Davide Campana, et al.. (2024). β1600 Q.Clear Digital Reconstruction of [68Ga]Ga-DOTANOC PET/CT Improves Image Quality in NET Patients. Journal of Clinical Medicine. 13(13). 3841–3841. 1 indexed citations

3.

Fanti, Stefano, et al.. (2024). The role of combined FDG and SST PET / CT in neuroendocrine tumors. Journal of Neuroendocrinology. 37(3). e13474–e13474. 3 indexed citations

4.

Allegri, Vincenzo, Davide Campana, Elisa Andrini, et al.. (2024). Real-Life Use of [68Ga]Ga-DOTANOC PET/CT in Confirmed and Suspected NETs from a Prospective 5-Year Electronic Archive at an ENETS Center of Excellence: More Than 2000 Scans in More Than 1500 Patients. Cancers. 16(4). 701–701. 3 indexed citations

5.

Sørbye, Halfdan, Enrique Grande, Marianne Pavel, et al.. (2023). European Neuroendocrine Tumor Society ( ENETS ) 2023 guidance paper for digestive neuroendocrine carcinoma. Journal of Neuroendocrinology. 35(3). e13249–e13249. 75 indexed citations breakdown →

6.

Zanoni, Lucia, et al.. (2023). Molecular imaging Theranostics of Neuroendocrine Tumors. Seminars in Nuclear Medicine. 53(4). 539–554. 13 indexed citations

7.

Rinke, Anja, Valentina Ambrosini, Clarisse Dromain, et al.. (2023). European Neuroendocrine Tumor Society ( ENETS ) 2023 guidance paper for colorectal neuroendocrine tumours. Journal of Neuroendocrinology. 35(6). e13309–e13309. 56 indexed citations

8.

Ambrosini, Valentina, et al.. (2020). Role of PET/CT and Therapy Management of Pancreatic Neuroendocrine Tumors. Diagnostics. 10(12). 1059–1059. 27 indexed citations

9.

Saponara, Maristella, Valentina Ambrosini, Margherita Nannini, et al.. (2018). ¹⁸F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature. Therapeutic Advances in Medical Oncology. 10. 3861408609–3861408609. 22 indexed citations

10.

Ghedini, Pietro, Irene Bossert, Lucia Zanoni, et al.. (2017). Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis. European Journal of Nuclear Medicine and Molecular Imaging. 45(5). 751–758. 9 indexed citations

11.

Barrio, Martin, Johannes Czernin, Stefano Fanti, et al.. (2017). The Impact of Somatostatin Receptor–Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis. Journal of Nuclear Medicine. 58(5). 756–761. 133 indexed citations

12.

Nanni, Cristina, Riccardo Schiavina, Stefano Boschi, et al.. (2013). Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results. European Journal of Nuclear Medicine and Molecular Imaging. 40(S1). 11–17. 90 indexed citations

13.

Nanni, Cristina, Luca Boriani, Caterina Salvadori, et al.. (2012). FDG PET/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis. European Journal of Nuclear Medicine and Molecular Imaging. 39(10). 1538–1544. 58 indexed citations

14.

Castellucci, Paolo, Chiara Fuccio, Domenico Rubello, et al.. (2010). Is there a role for 11C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml?. European Journal of Nuclear Medicine and Molecular Imaging. 38(1). 55–63. 129 indexed citations

15.

Nanni, Cristina, Antonella Marangoni, Carmelo Quarta, et al.. (2009). Small animal PET for the evaluation of an animal model of genital infection. Clinical Physiology and Functional Imaging. 29(3). 187–192. 8 indexed citations

16.

Ambrosini, Valentina, Carmelo Quarta, Cristina Nanni, et al.. (2009). Small Animal PET in Oncology: The Road from Bench to Bedside. Cancer Biotherapy and Radiopharmaceuticals. 24(2). 277–285. 8 indexed citations

17.

Ambrosini, Valentina, Paola Tomassetti, Paolo Castellucci, et al.. (2008). Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours. European Journal of Nuclear Medicine and Molecular Imaging. 35(8). 1431–1438. 175 indexed citations

18.

Lopci, Egesta, Roberta Burnelli, Valentina Ambrosini, et al.. (2008). ¹⁸ F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging. Cancer Biotherapy and Radiopharmaceuticals. 1–10. 3 indexed citations

19.

Lopci, Egesta, Roberta Burnelli, Valentina Ambrosini, et al.. (2008). ¹⁸ F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging. Cancer Biotherapy and Radiopharmaceuticals. 23(6). 681–690. 17 indexed citations

20.

Spinelli, Antonello E., Daniela D’Ambrosio, Cinzia Pettinato, et al.. (2006). Performance evaluation of a small animal PET scanner. Spatial resolution characterization using 18F and 11C. Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment. 571(1-2). 215–218. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact